Publications by authors named "Keith Bangerter"

Claim this Profile
A
Algorithm of Transvaginal Ultrasound and/or Hysterosalpingogram for Confirmation Testing at 3 Months after Essure Placement.
Michel Vleugels, Ru-Fong Cheng, Jeffrey Goldstein, Keith Bangerter, Viviane Connor

J Minim Invasive Gynecol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cycles.
Carolyn L Westhoff, Isabel Reinecke, Keith Bangerter, Martin Merz

Contraception· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study.
Raymond Rosen, Ridwan Shabsigh, Mark Berber, Pierre Assalian, Mathew Menza, Keith Bangerter

Am J Psychiatry· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial.
Irwin Goldstein, William A Fisher, Michael Sand, Raymond C Rosen, Martin Mollen, Keith Bangerter

J Sex Med· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil.
William A Fisher, Raymond C Rosen, Martin Mollen, Gerald Brock, Gary Karlin, Keith Bangerter

J Sex Med· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study.
Irwin Goldstein, Jay M Young, Jerome Fischer, Keith Bangerter, Thomas Segerson

Diabetes Care· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis